Natrijev Klorid Alkaloid-Int (Sodium Chloride)

The solution provides sodium (Na+) and chloride (Cl-) ions directly into the bloodstream. These ions expand the extracellular fluid volume, increase plasma osmolarity, and help correct electrolyte deficits, thereby supporting circulatory stability and normal cellular function.

The appropriate dose is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and laboratory values. Healthcare professionals calculate the required volume and infusion rate to safely achieve the desired fluid and electrolyte goals.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it must be prescribed by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natrijev Klorid Alkaloid-Int is a standard isotonic sodium chloride injection comparable to other 0.9% saline products. Its clinical efficacy and safety profile are similar, with differences mainly in manufacturing source, regulatory compliance, and supply chain reliability offered by GNH India.

Store the injection solution at ambient temperature, below 25 °C, in its original sealed container. Protect it from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the product, and inspect the vial for any particulate matter before use.

The solution is administered intravenously by slow infusion or bolus, as directed by the prescriber. Administration should be performed by qualified healthcare personnel using aseptic technique, with the infusion rate adjusted to the patient’s clinical status and monitoring requirements.

Serious risks include severe hypernatremia or hyperchloremia, which can lead to neurological symptoms or cardiac arrhythmias, as well as anaphylactic reactions and volume overload causing pulmonary edema. Prompt recognition and appropriate monitoring are essential to mitigate these risks.

Patients with known hypersensitivity to sodium chloride or any component of the formulation should avoid this product. It is also contraindicated in individuals with existing severe hypernatremia or uncontrolled fluid overload, unless a clinician determines that the benefits outweigh the risks.